Cambridge, MA · Founded 2011 · Privately Held (backing)
Developer of supramolecular therapeutics designed for cancer patients. Alyssum Therapeutics is based in Cambridge, MA and was founded in 2011. Its last reported valuation was $13.3 million in Mar 2017. It has raised $32.7 million.
Last reported valuation
$13.3M
Oct 2026
Priced at
—
Total raised
$32.7M
Last round
—
Team — not yet on record
No current team members for Alyssum Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Alyssum Therapeutics with a free account
·Watch Alyssum Therapeutics: the Monday email on marks, rounds and moves
